Objective: To investigate the performance of the Roche Accuchek Active glucometer in diagnosing gestational diabetes mellitus (GDM) versus the gold-standard laboratory test.
| INTRODUCTION
After decades of research, there is now almost universal consensus regarding the screening and diagnostic criteria for gestational diabetes mellitus (GDM).
1 Hyperglycemia in pregnancy is associated with adverse perinatal outcomes and increases long-term risks for both mother and child. [2] [3] [4] Despite investigations into other screening and diagnostic tests, the 75-g 2-hour oral glucose tolerance test (OGTT) remains the cornerstone of diagnosis. 5 Furthermore, there is a shift away from conducting traditional risk-factor-based screening among high-risk women only to universal screening for GDM among all pregnant women.
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The OGTT is not without limitations. Both a trained phlebotomist and laboratory facilities for glucose measurement are required.
In addition, the results of the OGTT are available only several days later, potentially necessitating more clinic visits by the woman.
With over a million pregnancies registered in South Africa every year, this places an enormous burden on the healthcare system and the pregnant women. To make universal screening for GDM feasible, a point-of-care
(POC) test for glucose with good accuracy and precision is required, especially in low-resource settings. 1 It is generally accepted in clinical practice that capillary blood glucose and venous plasma glucose measurements are comparable. [7] [8] [9] However, laboratory tests are performed on venous plasma, whereas POC tests are usually performed on capillary whole blood. Glucose levels vary depending on the source of the blood sample used for analysis; this variation is attributed to differences in glucose extraction by tissues, perfusion, oxygenation, pH, and temperature. 10 The increased volume of distribution associated with pregnancy may further affect these measurements. ing, evidence regarding their use for GDM diagnosis. [14] [15] [16] The aim of the present study was therefore to investigate the performance of the Roche Accuchek Active glucometer, which is the most commonly available POC device in the study setting, in the diagnosis of GDM.
| MATERIALS AND METHODS
The present analysis formed part of a larger study of screening strategies for GDM in South Africa. In a prospective cohort observational study, 1000 pregnant women were recruited at a primary healthcare The sample size was calculated by using a 5% margin of error and a 95% confidence interval (CI), which determined that 400 women would be needed to complete the study. Considering loss to follow-up (50%), pregnancy loss (15%), and patient migration (20%), a sample size of 1000 (to the nearest 100) was calculated.
Women at less than 26 gestational weeks were recruited. Those known to have diabetes mellitus or were more than 26 weeks pregnant were excluded.
At recruitment, each woman completed a questionnaire of demographic data and underwent an evaluation of risk factors for GDM. four different lot numbers were used so that all test strips remained within their expiration date; however differences in test strips used for glucometers might diminish analytical quality because studies have shown that significant variability exists between test strips. 22, 23 The study data were analyzed by using Stata version 13 should be within 15% for at least 99% of samples tested.
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Multiple statistical methods were used to analyze the accuracy of the glucometer. Bland-Altman plots were generated for glucose measurements at 0 hours, 1 hour, and 2 hour to assess agreement between the glucometer and laboratory assays. Acceptable limits of agreement were defined as −0.5 to +0.5. The coefficient of variation (CV), defined as the ratio of the SD to the mean, was determined to assess variability, and a CV of less than 5% was taken as acceptable.
The Youden index (J) was used to evaluate the performance of the glucometer test, and was calculated by the formula J=sensitivity + specificity − 1. Receiver operator characteristic (ROC) curve analysis was used to determine the sensitivity and specificity of the glucometer for the diagnosis of GDM in clinical practice. A P value of less than 0.05 was considered to be statistically significant.
| RESULTS
Of the 1000 pregnant women recruited, 82 (8.2%) experienced fetal loss and did not complete the study, 163 (16.3%) moved from the area, 194 (19.4%) were lost to follow-up, and 7 (0.7%) withdrew consent.
In addition, the paired glucose data were incomplete for 25 (2.5%)
women. Thus, 529 (52.9%) women had complete data and formed the study population (Table 1) . The mean glucose levels at 0 hours, 1 hour and 2 hours of the OGTT measured by the laboratory and the glucometer are shown in Table 2 .
The CV of the glucometer test was 16%, 17%, and 15% at 0, 1, 2 hours, respectively, indicating poor precision of the Roche Accuchek
Active glucometer relative to laboratory measurements, which range from 0.97% to 3.41%.
The glucometer results were evaluated in terms of the ISO guidelines (Table 3) The glucometer was found to have a sensitivity of 27.0% and a specificity of 89.4% (Table 4 ). The Youden index was 0.16 and accuracy was calculated to be 72.8%.
Clinical accuracy was further evaluated by scatter plots (Fig. 2) . 
| DISCUSSION
The present study found that the glucometer performed poorly as compared with the laboratory when used for the diagnosis of GDM.
It did not meet the ISO criteria and so has poor analytic accuracy. 24 It also has poor clinical accuracy, as demonstrated by the large number of women with GDM who would not have been diagnosed if their glucose level had been measured only by glucometer (Table 4) .
Previous studies investigating a POC glucometer for the diagnosis of GDM have recommended its use in clinical practice. 14-16 A recent South African study found that most glucometers were acceptable, although the authors warned about the variability among different meters and the need for independent comparison. 25 The present study found that the Roche Accuchek Active glucometer performed poorly when used for the diagnosis of GDM. This is consistent with a review of POC glucometers that found that a reliable glucose reading relative to the laboratory reference is achieved only by approximately 50% of POC meters.
26
In the present study, the glucometer was found to have poor sensitivity and specificity for the diagnosis of GDM. Overall, 103 (19.5%) cases of GDM would not have been diagnosed by the glucometer alone. Numerous variables can affect the measured glucose level, including the POC device or test strips, patient medications, hematocrit level, blood pH, the site from which blood was obtained, and the detection method used by the POC device. 27 Balaji et al.
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also investigated the use of a glucometer in a low-resource setting, and reported a poor correlation between the glucometer and the laboratory. They suggested using a lower cut-off for the capillary reading; however, their proposal to use the glucometer as a screening tool would necessitate two OGTTs, which would increase the number of visits to the clinic and might also deter women from have the test at all owing to the adverse effects of the oral glucose load.
It was previously demonstrated that capillary glucose values are higher than venous glucose readings. 10 In the present study, however, Most cases of GDM in the study were diagnosed on the basis of fasting glucose. We considered the possibility of applying a correction factor to the glucometer, but were unable to derive a simple userfriendly formula. Furthermore, correction factors do not perform well when applied to the general population, and thus would not be feasible in a universal screen for GDM.
The advantages of the study include its large patient numbers in a low-resource real-world setting. In addition, two research nurses were used to minimize variability (two research nurses were needed to accommodate their other commitments during the study period). The study also has limitations. First, only one POC glucometer system was tested, and four lots of test strips were used, thereby increasing variability. For the laboratory test, blood was not centrifuged within the recommended 30 minutes owing to the distance between the laboratory and the clinic. Last, citrate tubes were not used for the collection of venous blood for glucose measurements.
The use of a POC device remains an alluring tool for the diagnosis of GDM. There have been conflicting results from recent studies. 19, 20 Whereas Balaji et al. 19 found a poor correlation, Jadhav et al.
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reported 100% correlation between the glucometer and the laboratory. It can be concluded that glucometers have variable performance and should be used cautiously for the diagnosis of GDM.
T A B L E 4 Diagnostic characteristics of point-of-care device in the diagnosis of GDM (n=529). On the basis of the present study, use of the Roche Accuchek
Active glucometer for the diagnosis of GDM cannot be recommended.
There is a need to test and improve the accuracy and precision of POC glucometers for the diagnosis of GDM. Newer technologies, such as smartphone measurements of glucose or continuous glucose monitoring, might have to be considered as alternatives to the OGTT for the diagnosis of GDM.
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